NCT00487097

Brief Summary

The purpose of this study is to investigate whether the addition of omega-3 and antioxidants to nutritional support in critically ill patients in the intensive care unit influences the immune and anti-inflammatory systems and so improves wound healing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2007

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 15, 2007

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2007

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
Last Updated

February 18, 2013

Status Verified

February 1, 2013

Enrollment Period

2.7 years

First QC Date

June 14, 2007

Last Update Submit

February 15, 2013

Conditions

Keywords

intensive carecritically illfish oilpressure sores

Outcome Measures

Primary Outcomes (1)

  • Improvement of wound healing of pressure sores

    within 28 days

Secondary Outcomes (1)

  • Improvement in parameters of immunity and inflammation

    Within 28 days

Study Arms (2)

Study Group

EXPERIMENTAL

Enteral Nutrition with Omega 3 (Eicosapentanoic acid, docosahexaenoic acid)

Dietary Supplement: Eicosapentanoic acid, docosahexaenoic acid

Control Group

NO INTERVENTION

Patients in control group will receive nutritional support composed of a standard formula

Interventions

Enteral nutrition formula enriched with Eicosapentanoic acid, docosahexaenoic acid

Also known as: OXEPA
Study Group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Critically ill patients in intensive care unit
  • Grade 2 pressure sores

You may not qualify if:

  • Immunosuppression with steroids or other agents
  • Active bleeding
  • Head trauma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rabin Medical center

Petah Tikva, 49100, Israel

Location

Related Publications (1)

  • Theilla M, Schwartz B, Cohen J, Shapiro H, Anbar R, Singer P. Impact of a nutritional formula enriched in fish oil and micronutrients on pressure ulcers in critical care patients. Am J Crit Care. 2012 Jul;21(4):e102-9. doi: 10.4037/ajcc2012187.

MeSH Terms

Conditions

Pressure UlcerCritical Illness

Interventions

Eicosapentaenoic AcidDocosahexaenoic Acids

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Fatty Acids, Omega-3Dietary Fats, UnsaturatedDietary FatsFatsLipidsEicosanoidsFatty Acids, UnsaturatedFatty AcidsFish OilsOils

Study Officials

  • Pierre Singer

    Rabin Medical Center, Beilison Hospital, Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, MD

Study Record Dates

First Submitted

June 14, 2007

First Posted

June 15, 2007

Study Start

September 1, 2007

Primary Completion

May 1, 2010

Study Completion

May 1, 2010

Last Updated

February 18, 2013

Record last verified: 2013-02

Locations